Measuring Expectations: Real-World Survival With Osimertinib
Over the past few years, osimertinib has received much fanfare among lung cancer experts. Results from the phase 3 LAURA trial...
Margarete Kucera
Over the past few years, osimertinib has received much fanfare among lung cancer experts. Results from the phase 3 LAURA trial...
